ENTX Entera Bio Ltd. - Ordinary Shares
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 7, 2026
$2,86
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$0,9152-Wochen-Tief
$4,2052-Wochen-Hoch
Marktkapitalisierung (MRQ)
$141M
P/E (TTM)
8.4
EPS (TTM)
$0.34
Umsatz (TTM)
$0
Ihre Abzeichen
52W-Spanne
$1–$4
Analystenbewertung
BUY
Kursziel
$10
P/E
8.4
ROE
-138.9%
Nettogewinnmarge
-27235.7%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
ENTX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.86
Marktkapitalisierung (MRQ)
$141M
P/E (TTM)
8.4
EPS (TTM)
$0.34
Umsatz (TTM)
$0
ROE (TTM)
-138.9%
52W-Spanne
$1–$4
ENTX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$42.0K2018-12-31 → 2025-12-31
EPS$0.252016-12-31 → 2025-12-31
Freier Cashflow$-7M2018-12-31 → 2025-12-31
Nettogewinnmarge-27235.7%2018-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | ENTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 8.45-Jahres-Durchschnitt ≈5.2 | ≈5.2 | · | · | |
| P/S | 3144.55-Jahres-Durchschnitt ≈915.0 | ≈915.0 | · | · | |
| K/B (MRQ) | 19.45-Jahres-Durchschnitt ≈5.2 | ≈5.2 | · | · | |
| Kurs / FCF (TTM) | -12.95-Jahres-Durchschnitt ≈-7.2 | ≈-7.2 | · | · | |
| Kurs / Cashflow (TTM) | -12.95-Jahres-Durchschnitt ≈-7.2 | ≈-7.2 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 10.15-Jahres-Durchschnitt ≈4.9 | ≈4.9 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | ENTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Gross Margin (Bruttogewinnmarge) | 0.00%5-Jahres-Durchschnitt ≈9.9% | ≈9.9% | 64.8% | Schwach | |
| Operating Margin (Betriebsgewinnmarge) | -27450.0%5-Jahres-Durchschnitt ≈-14153.3% | ≈-14153.3% | 7.3% | Schwach | |
| EBITDA Margin (EBITDA-Marge) | -27450.0%5-Jahres-Durchschnitt ≈-14153.3% | ≈-14153.3% | 7.9% | Schwach | |
| Pretax Margin (Vorgewinnmarge) | -27235.7%5-Jahres-Durchschnitt ≈-14050.5% | ≈-14050.5% | 0.48% | Schwach | |
| Net Profit Margin (Nettogewinnmarge) | -27235.7%5-Jahres-Durchschnitt ≈-14087.2% | ≈-14087.2% | -4.3% | Schwach | |
| ROA (TTM) | -87.0%5-Jahres-Durchschnitt ≈-79.6% | ≈-79.6% | -28.9% | Schwach | |
| ROE (TTM) | -138.9%5-Jahres-Durchschnitt ≈-103.5% | ≈-103.5% | 26.2% | Schwach | |
| ROIC | -88.0%5-Jahres-Durchschnitt ≈-101.2% | ≈-101.2% | -39.8% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | ENTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 9.05-Jahres-Durchschnitt ≈8.6 | ≈8.6 | 5.3 | Starke Liquidität | |
| Quick Ratio | 3.25-Jahres-Durchschnitt ≈7.5 | ≈7.5 | 3.8 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | ENTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -76.8%5-Jahres-Durchschnitt ≈-32.3% | ≈-32.3% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -32.1% | · | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | -35.1% | · | · | · | |
| EPS YoY (EPS VjV) | 0.00%5-Jahres-Durchschnitt ≈-13.7% | ≈-13.7% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | -17.8% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | ENTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.05-Jahres-Durchschnitt ≈0.0 | ≈0.0 | 0.5 | Schwach | |
| Receivables Turnover (Forderungsumschlag) | 0.75-Jahres-Durchschnitt ≈1.0 | ≈1.0 | · | · | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$2.1K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
17.0%
Nächster Bericht
Nov 12, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 7, 2026 | $-0.14 | $-0.08 | -71.6% |
| 31. März 2026 | Mai 8, 2026 | $-0.07 | $-0.15 | 54.2% |
| 31. Dezember 2025 | $-0.07 | $-0.09 | 23.7% | |
| 30. September 2025 | $-0.07 | $-0.09 | 23.7% | |
| 30. Juni 2025 | $-0.06 | $-0.11 | 46.5% | |
| 31. März 2025 | $-0.06 | $-0.07 | 16.0% | |
| 31. Dezember 2024 | $-0.06 | $-0.08 | 26.5% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $42.0K | $181.0K | $0 | $134.0K | $571.0K | $365.0K | $236.0K | $500.0K | |
| Cost of Revenue | $42.0K | $172.0K | $0 | $101.0K | $373.0K | $300.0K | $210.0K | · | |
| Gross Profit | $0 | $9.0K | $0 | $33.0K | $198.0K | $65.0K | · | · | |
| R&D Expense | $6M | $4M | $5M | $6M | $7M | $6M | $7M | $9M | |
| SG&A Expense | $398.0K | $340.0K | $4M | $7M | $6M | $5M | $4M | $3M | |
| Operating Expenses | $12M | $10M | $9M | $13M | $12M | $11M | · | · | |
| Operating Income | $-12M | $-10M | $-9M | $-13M | $-12M | $-11M | $-11M | $-11M | |
| Other Non-op | $90.0K | $58.0K | $31.0K | $83.0K | $-29.0K | $-28.0K | · | · | |
| Pretax Income | $-11M | $-10M | $-9M | $-13M | $-12M | $-11M | $-11M | $-10M | |
| Income Tax | $0 | $14.0K | $29.0K | $137.0K | $-59.0K | $20.0K | · | · | |
| Net Income | $-11M | $-10M | $-9M | $-13M | $-12M | $-11M | $-11M | $-10M | |
| EPS (Basic) | $0.25 | $0.25 | $0.31 | $0.45 | $0.47 | $0.54 | $0.89 | $1.30 | |
| EPS (Diluted) | $0.25 | $0.25 | $0.31 | $0.45 | $0.47 | $0.55 | $0.89 | $1.31 | |
| Shares (Basic) | 46,191,067 | 37,650,179 | 29,007,794 | 28,808,090 | 26,133,770 | 18,417,093 | 12,146,729 | 7,955,447 | |
| Shares (Diluted) | 46,191,067 | 37,650,179 | 29,007,794 | 28,808,090 | 26,133,770 | 18,563,675 | 12,146,729 | 7,983,402 | |
| EBITDA | $-12M | $-10M | $-9M | $-13M | · | $-11M | $-11M | $-11M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $9M | $11M | $12M | $25M | $9M | $15M | $8M | |
| Receivables | $0 | $126.0K | $0 | $246.0K | $183.0K | $255.0K | $278.0K | $725.0K | |
| Prepaid Expense | $415.0K | $29.0K | $238.0K | $294.0K | · | · | · | · | |
| Other Current Assets | $107.0K | $186.0K | $238.0K | $294.0K | $254.0K | $261.0K | · | · | |
| Current Assets | $15M | $9M | $11M | $13M | $25M | $9M | $16M | $12M | |
| PP&E (Net) | $134.0K | $57.0K | $100.0K | $139.0K | $156.0K | $192.0K | $202.0K | $224.0K | |
| Intangibles | · | · | · | · | · | $605.0K | $605.0K | $651.0K | |
| Total Assets | $16M | $9M | $12M | $13M | $26M | $10M | $17M | $13M | |
| Accounts Payable | $448.0K | $132.0K | $83.0K | $17.0K | $166.0K | $164.0K | $1M | $1M | |
| Current Liabilities | $2M | $1M | $1M | $1M | $3M | $2M | $5M | $3M | |
| Capital Leases | $260.0K | $102.0K | $256.0K | $0 | $123.0K | $243.0K | · | · | |
| Other Non-current Liabilities | $393.0K | $0 | · | · | · | · | · | · | |
| Total Liabilities | $3M | $1M | $1M | $1M | $3M | $2M | $5M | $3M | |
| Common Stock | $1.0K | $1.0K | $1.0K | · | · | · | · | · | |
| Retained Earnings | $-125M | $-114M | $-104M | $-95M | $-82M | $-70M | $-63M | $-52M | |
| AOCI | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | · | · | |
| Stockholders' Equity | $13M | $8M | $10M | $12M | $23M | $8M | $14M | $10M | |
| Liabilities + Equity | $16M | $9M | $12M | $13M | $26M | $10M | · | · | |
| Shares Outstanding | 46,178,630 | 38,837,220 | 35,476,341 | 28,809,922 | 28,804,411 | 21,057,922 | · | · |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | $225.0K | $238.0K | $54.0K | |
| Stock-based Comp | $3M | $3M | $2M | $2M | $2M | $901.0K | · | · | |
| Deferred Tax | $0 | $14.0K | $29.0K | $174.0K | $-217.0K | $0 | · | · | |
| Other Non-cash | · | · | · | · | · | $-665.0K | $2M | $454.0K | |
| Operating Cash Flow | $-7M | $-7M | $-7M | $-12M | $-9M | $-11M | $-9M | $-10M | |
| CapEx | $107.0K | $3.0K | $17.0K | $47.0K | $17.0K | $53.0K | $40.0K | $68.0K | |
| Investing Cash Flow | $-107.0K | $-3.0K | $-17.0K | $-102.0K | $-17.0K | $-53.0K | $4M | $-4M | |
| Stock Issued | $6M | $4M | $5.0K | $0 | $22M | $3M | · | · | |
| Net Stock Activity | $6M | $4M | $5.0K | $0 | · | · | · | · | |
| Financing Cash Flow | $14M | $4M | $6M | $13.0K | $25M | $4M | $13M | $10M | |
| Net Change in Cash | $6M | $-2M | $-1M | $-13M | $16M | $-7M | · | · | |
| Taxes Paid | · | · | $0 | $165.0K | $2.0K | $89.0K | · | · | |
| Free Cash Flow | $-7M | $-7M | $-7M | $-13M | · | $-10M | $-9M | $-10M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 0.00% | 5.0% | · | 24.6% | · | · | · | · | |
| Operating Margin | -27450.0% | -5295.6% | · | -9714.2% | · | -3050.1% | -4853.4% | -2172.2% | |
| Net Margin | -27235.7% | -5271.3% | · | -9754.5% | · | -2735.1% | -4574.2% | -2060.8% | |
| Pretax Margin | -27235.7% | -5263.5% | · | -9652.2% | · | -2729.6% | · | · | |
| EBITDA Margin | -27450.0% | -5295.6% | · | -9714.2% | · | -2988.5% | -4752.5% | -2161.4% | |
| ROA | -90.1% | -90.2% | -71.4% | -66.8% | · | -74.0% | -71.9% | -77.4% | |
| ROE | -75.4% | -131.3% | -106.9% | -100.3% | · | -97.7% | -98.0% | 96.1% | |
| ROIC | -88.0% | -118.8% | -85.9% | -111.9% | · | -167.4% | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.9 | 7.6 | 10.3 | 9.6 | · | 2.8 | 3.4 | 7.0 | |
| Quick Ratio | 3.2 | 7.5 | 10.1 | 9.4 | · | 2.7 | 3.4 | 4.6 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | 0.7 | 2.9 | 0.0 | 0.6 | · | 1.4 | 0.5 | 1.4 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.28 | $0.21 | $0.29 | $0.41 | · | · | · | · | |
| Revenue / Share | $0.00 | $0.00 | $0.00 | $0.00 | · | $0.02 | $0.02 | $0.06 | |
| Cash Flow / Share | $-0.16 | $-0.18 | $-0.25 | $-0.43 | · | $-0.56 | $-0.73 | $-1.23 | |
| Cash / Share | $0.15 | $0.22 | $0.31 | $0.43 | · | · | · | · | |
| EPS (TTM) | $0.25 | $0.25 | $0.31 | $0.45 | $0.47 | $0.55 | $0.89 | $1.31 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -76.8% | · | · | -76.5% | 56.4% | · | · | · | |
| Revenue CAGR 3Y | -32.1% | -31.8% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -35.1% | · | · | · | · | · | · | · | |
| EPS YoY | 0.00% | -19.4% | -31.1% | -4.3% | · | · | · | · | |
| EPS CAGR 3Y | -17.8% | -19.0% | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $42.0K | $181.0K | $0 | $134.0K | $571.0K | $365.0K | $236.0K | $500.0K | |
| Net Income TTM | $-11M | $-10M | $-9M | $-13M | $-12M | $-11M | $-11M | $-10M | |
| Market Cap | $90M | $82M | $21M | $21M | · | · | · | · | |
| P/E | 7.8 | 8.5 | 1.9 | 1.6 | 6.0 | 2.0 | 2.4 | 2.3 | |
| P/S | 2133.0 | 454.9 | · | 156.9 | · | · | · | · | |
| P/B | 6.8 | 10.2 | 2.0 | 1.8 | · | · | · | · | |
| P / Tangible Book | 6.8 | 10.2 | 2.0 | 1.8 | 3.6 | · | · | · | |
| P / Cash Flow | -12.2 | -12.1 | -2.9 | -1.7 | · | · | · | · | |
| P / FCF | -12.0 | -12.1 | -2.9 | -1.7 | · | · | · | · | |
| Earnings Yield | 12.9% | 11.8% | 51.7% | 61.6% | 16.7% | 50.9% | 41.6% | 43.0% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $42.0K | $82.0K | $42.0K | $57.0K | $0 | $0 | $0 | $0 | $0 | $14.0K | $8.0K | |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $42.0K | $82.0K | $42.0K | $48.0K | $0 | $0 | $0 | $0 | $0 | $8.0K | $6.0K | |
| Gross Profit | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $9.0K | · | $0 | $0 | $0 | $0 | $6.0K | $2.0K | |
| R&D Expense | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $735.0K | $1M | $1M | $1M | $931.0K | $1M | $1M | |
| SG&A Expense | $124.0K | $128.0K | $-1M | $122.0K | $103.0K | $123.0K | $-1M | $62.0K | $134.0K | $1M | $973.0K | $1M | $1M | $1M | $2M | $1M | |
| Operating Expenses | $5M | $4M | $3M | $3M | $3M | $3M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | |
| Operating Income | $-5M | $-4M | $-3M | $-3M | $-3M | $-3M | $-2M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | |
| Other Non-op | $-3M | $34.0K | $26.0K | $56.0K | $12.0K | $-4.0K | $-7.0K | $0 | $20.0K | $45.0K | $-32.0K | $36.0K | $5.0K | $22.0K | $-13.0K | $-8.0K | |
| Pretax Income | · | · | · | · | · | · | $-2M | $-3M | · | · | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | |
| Income Tax | · | · | · | · | · | · | $14.0K | $0 | · | · | $0 | $29.0K | $0 | $0 | $-46.0K | $194.0K | |
| Net Income | $-7M | $-4M | $-3M | $-3M | $-3M | $-3M | $-2M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | |
| EPS (Basic) | $0.14 | $0.07 | $0.06 | $0.07 | $0.06 | $0.06 | $0.06 | $0.08 | $0.06 | $0.05 | $0.07 | $0.08 | $0.08 | $0.08 | $0.10 | $0.11 | |
| EPS (Diluted) | $0.14 | $0.07 | $0.06 | $0.07 | $0.06 | $0.06 | $0.06 | $0.08 | $0.06 | $0.05 | $0.07 | $0.08 | $0.08 | $0.08 | $0.10 | $0.11 | |
| Shares (Basic) | 50,451,232 | 47,756,409 | · | 47,089,814 | 46,836,700 | 43,377,391 | · | 37,644,612 | 37,090,160 | 36,735,429 | · | 28,813,952 | 28,812,375 | 28,809,922 | · | 28,809,922 | |
| Shares (Diluted) | 50,451,232 | 47,756,409 | · | 47,089,814 | 46,836,700 | 43,377,391 | · | 37,644,612 | 37,090,160 | 36,735,429 | · | 28,813,952 | 28,812,375 | 28,809,922 | · | 28,809,922 | |
| EBITDA | $-5M | $-4M | · | $-3M | $-3M | $-3M | · | $-3M | $-2M | $-2M | · | $-2M | $-2M | $-2M | · | $-3M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $4M | $7M | $9M | $11M | $13M | $9M | $7M | $9M | $9M | $11M | $8M | $9M | $11M | $12M | $14M | |
| Receivables | · | · | $0 | $0 | $0 | $126.0K | $126.0K | $42.0K | $57.0K | · | $0 | $0 | $29.0K | $29.0K | $246.0K | $233.0K | |
| Prepaid Expense | $465.0K | $566.0K | $37.0K | $405.0K | $438.0K | $519.0K | $29.0K | $383.0K | $482.0K | $562.0K | · | $431.0K | $650.0K | · | · | · | |
| Other Current Assets | $144.0K | $256.0K | $415.0K | $262.0K | $192.0K | $165.0K | $186.0K | $89.0K | $67.0K | $39.0K | $238.0K | $263.0K | $354.0K | $653.0K | $294.0K | $634.0K | |
| Current Assets | $19M | $12M | $15M | $17M | $19M | $21M | $9M | $7M | $10M | $10M | $11M | $8M | $10M | $11M | $13M | $15M | |
| PP&E (Net) | $121.0K | $127.0K | $134.0K | $114.0K | $79.0K | $57.0K | $57.0K | $65.0K | $76.0K | $87.0K | $100.0K | $108.0K | $122.0K | $136.0K | $139.0K | $152.0K | |
| Total Assets | $19M | $13M | $16M | $17M | $20M | $22M | $9M | $8M | $10M | $10M | $12M | $9M | $10M | $12M | $13M | $16M | |
| Accounts Payable | $575.0K | $274.0K | $448.0K | $216.0K | $383.0K | $134.0K | $132.0K | $184.0K | $69.0K | $66.0K | $83.0K | $564.0K | $240.0K | $150.0K | $17.0K | $413.0K | |
| Current Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $1M | $1M | $1M | |
| Capital Leases | $226.0K | $263.0K | $260.0K | $41.0K | $9.0K | $51.0K | $102.0K | $147.0K | $179.0K | $224.0K | $256.0K | $271.0K | $316.0K | · | $0 | $3.0K | |
| Other Non-current Liabilities | · | · | $393.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $12M | $2M | $3M | $2M | $2M | $2M | $1M | $1M | $2M | $1M | $1M | $2M | $2M | $2M | $1M | $1M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | · | · | · | · | · | |
| Retained Earnings | $-136M | $-129M | $-125M | $-122M | $-119M | $-116M | $-114M | $-112M | $-109M | $-106M | $-104M | $-102M | $-100M | $-98M | $-95M | $-92M | |
| AOCI | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | |
| Stockholders' Equity | $7M | $11M | $13M | $15M | $17M | $19M | $8M | $6M | $9M | $9M | $10M | $6M | $8M | $10M | $12M | $14M | |
| Liabilities + Equity | $19M | $13M | $16M | $17M | $20M | $22M | $9M | $8M | $10M | $10M | $12M | $9M | $10M | $12M | $13M | $16M | |
| Shares Outstanding | 49,290,233 | 46,622,239 | 46,178,630 | 45,664,506 | 45,452,167 | 45,420,677 | 38,837,220 | 36,512,214 | 36,314,579 | 35,526,281 | 35,476,341 | 28,813,952 | 28,813,952 | 28,809,922 | 28,809,922 | 28,809,922 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $624.0K | $672.0K | $710.0K | $927.0K | $509.0K | $604.0K | $566.0K | $928.0K | $598.0K | $464.0K | $318.0K | $383.0K | $472.0K | $516.0K | $477.0K | $110.0K | |
| Deferred Tax | · | · | · | · | · | · | $14.0K | · | · | · | $0 | $29.0K | $0 | $0 | $23.0K | $214.0K | |
| Operating Cash Flow | $-3M | $-3M | $-2M | $-3M | $-2M | $-1M | $-1M | $-2M | $-1M | $-2M | $-3M | $-2M | $-2M | $-2M | $-2M | $-3M | |
| CapEx | $3.0K | $0 | $27.0K | $43.0K | $29.0K | $8.0K | $3.0K | $0 | $0 | $0 | $5.0K | $0 | $1.0K | $11.0K | $3.0K | $2.0K | |
| Investing Cash Flow | $-3.0K | $0 | $-27.0K | $-43.0K | $-29.0K | $-8.0K | $-3.0K | $0 | $0 | $0 | $-5.0K | $0 | $-1.0K | $-11.0K | $-3.0K | $-57.0K | |
| Stock Issued | $0 | $0 | $0 | $71.0K | $0 | $6M | $3M | $19.0K | $620.0K | $0 | $0 | $0 | · | · | $0 | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $6M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $10M | $130.0K | $174.0K | $250.0K | $-51.0K | $13M | $3M | $13.0K | $1M | $30.0K | $6M | $0 | $5.0K | $0 | $0 | $0 | |
| Net Change in Cash | · | · | · | · | $-2M | $12M | $2M | $-2M | $-119.0K | $-2M | $3M | $-2M | $-2M | $-2M | $-2M | $-3M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Free Cash Flow | · | $-3M | · | · | · | $-1M | · | · | · | $-2M | · | · | · | $-2M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 0.00% | · | 0.00% | 15.8% | · | · | · | · | · | · | 25.0% | |
| Operating Margin | · | · | · | · | · | -6102.4% | · | -7192.9% | -3798.2% | · | · | · | · | · | · | -35812.5% | |
| Net Margin | · | · | · | · | · | -6111.9% | · | -7192.9% | -3763.2% | · | · | · | · | · | · | -38337.5% | |
| Pretax Margin | · | · | · | · | · | · | · | -7192.9% | · | · | · | · | · | · | · | -35912.5% | |
| EBITDA Margin | · | · | · | · | · | -6102.4% | · | -7192.9% | -3798.2% | · | · | · | · | · | · | -35812.5% | |
| ROA | -37.4% | -20.2% | · | -25.4% | -17.9% | -16.1% | · | -37.0% | -20.9% | -18.5% | · | -19.7% | -15.8% | -12.9% | · | -39.5% | |
| ROE | -59.6% | -23.3% | · | -29.5% | -20.6% | -18.2% | · | -47.6% | -25.6% | -21.3% | · | -23.2% | -18.2% | -14.7% | · | -42.9% | |
| ROIC | · | · | · | · | · | · | · | -46.8% | · | · | · | -38.7% | -28.3% | -21.9% | · | -21.4% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.0 | 7.9 | · | 10.8 | 10.5 | 13.1 | · | 6.6 | 7.4 | 8.7 | · | 4.0 | 5.3 | 7.6 | · | 12.7 | |
| Quick Ratio | 5.4 | 2.6 | · | 5.5 | 5.9 | 7.8 | · | 6.3 | 7.0 | 8.2 | · | 3.7 | 4.9 | 7.2 | · | 12.2 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | 0.0 | 0.0 | 0.5 | · | 2.0 | 1.3 | · | · | 0.0 | 0.0 | 0.0 | · | 0.1 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.15 | $0.23 | · | $0.33 | $0.38 | $0.43 | · | $0.18 | $0.23 | $0.25 | · | $0.22 | $0.29 | $0.35 | · | $0.50 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | · | · | $0.00 | $0.00 | $0.00 | · | $0.00 | |
| Cash Flow / Share | · | $-0.06 | · | · | · | $-0.03 | · | · | · | $-0.05 | · | · | · | $-0.06 | · | · | |
| Cash / Share | $0.23 | $0.09 | · | $0.19 | $0.24 | $0.28 | · | $0.19 | $0.25 | $0.26 | · | $0.26 | $0.32 | $0.37 | · | $0.50 | |
| EPS (TTM) | $0.34 | $0.26 | · | $0.25 | $0.26 | $0.26 | · | $0.26 | $0.26 | $0.28 | · | $0.34 | $0.37 | $0.40 | · | $0.50 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $124.0K | $166.0K | $223.0K | · | $99.0K | $57.0K | $0 | · | $14.0K | $22.0K | $66.0K | · | $285.0K | |
| Net Income TTM | $-17M | $-12M | · | $-11M | $-11M | $-10M | · | $-9M | $-9M | $-9M | · | $-10M | $-11M | $-11M | · | $-14M | |
| Market Cap | $87M | $52M | · | $88M | $86M | $77M | · | $69M | $67M | $59M | · | $21M | $24M | $33M | · | $30M | |
| P/E | 5.2 | 4.3 | · | 7.7 | 7.3 | 6.5 | · | 7.3 | 7.1 | 6.0 | · | 2.1 | 2.3 | 2.9 | · | 2.1 | |
| P/S | · | · | · | 707.1 | 520.2 | 346.3 | · | 700.7 | 1172.3 | · | · | 1492.2 | 1104.1 | 506.4 | · | 105.1 | |
| P/B | 12.0 | 4.8 | · | 5.8 | 5.0 | 4.0 | · | 10.8 | 7.8 | 6.7 | · | 3.3 | 3.0 | 3.3 | · | 2.1 | |
| P / Tangible Book | 12.0 | 4.8 | · | 5.8 | 5.0 | 4.0 | · | 10.8 | 7.8 | 6.7 | · | 3.3 | 3.0 | 3.3 | · | 2.1 | |
| P / Cash Flow | · | -16.7 | · | · | · | -55.0 | · | · | · | -31.9 | · | · | · | -20.8 | · | · | |
| Earnings Yield | 19.2% | 23.4% | · | 13.0% | 13.7% | 15.3% | · | 13.7% | 14.1% | 16.8% | · | 46.9% | 43.9% | 34.5% | · | 48.1% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $42.0K | $181.0K | $0 | $134.0K | $571.0K |
| Bruttogewinnmarge % | 0.00% | 5.0% | · | 24.6% | · |
| Betriebsgewinnmarge % | -27450.0% | -5295.6% | · | -9714.2% | · |
| Nettoergebnis | $-11M | $-10M | $-9M | $-13M | $-12M |
| Verwässerte EPS | $0.25 | $0.25 | $0.31 | $0.45 | $0.47 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 6.9 | 7.6 | 10.3 | 9.6 | · |
| Quick Ratio | 3.2 | 7.5 | 10.1 | 9.4 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-7M | $-7M | $-7M | $-13M | · |
Institutionelle Eigentümer (13F) 29 Einreicher · $18.8M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
29
Gehaltener Wert
$18.8M
Neue Positionen
8
Geschlossene Positionen
6
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 8 (0 vs. Vorquartal) | 6 (+2 vs. Vorquartal) | 8 (+3 vs. Vorquartal) | 6 (-1 vs. Vorquartal) | +2.9M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Knoll Capital Management, LLC | $10.410.925 | 5.881.879 | 55,39% | Aktien |
| BVF INC/IL | $4.292.250 | 2.425.000 | 22,84% | Aktien |
| Siren, L.L.C. | $1.303.529 | 736.457 | 6,94% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $652.859 | 368.847 | 3,47% | Aktien |
| Parkman Healthcare Partners LLC | $485.860 | 274.497 | 2,59% | Aktien |
| PNC Financial Services Group, Inc. | $483.265 | 273.031 | 2,57% | Aktien |
| Seven Fleet Capital Management LP | $338.697 | 191.354 | 1,80% | Aktien |
| HighTower Advisors, LLC | $132.935 | 74.573 | 0,71% | Aktien |
| Schonfeld Strategic Advisors LLC | $104.201 | 58.871 | 0,55% | Aktien |
| TWO SIGMA SECURITIES, LLC | $86.010 | 48.593 | 0,46% | Aktien |
| SIGNATURE ESTATE & INVESTMENT ADVISORS LLC | $83.771 | 47.328 | 0,45% | Aktien |
| CITADEL ADVISORS LLC | $68.683 | 38.804 | 0,37% | Aktien |
| JPMORGAN CHASE & CO | $67.457 | 40.883 | 0,36% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $52.937 | 29.908 | 0,28% | Aktien |
| DIADEMA PARTNERS LP | $41.170 | 23.260 | 0,22% | Aktien |
| XTX Topco Ltd | $36.389 | 20.559 | 0,19% | Aktien |
| Gem Investment Advisors, LLC | $33.869 | 19.135 | 0,18% | Aktien |
| JANE STREET GROUP, LLC | $30.676 | 17.331 | 0,16% | Aktien |
| SIMPLEX TRADING, LLC | $27.785 | 15.698 | 0,15% | Aktien |
| UBS Group AG | $22.520 | 12.723 | 0,12% | Aktien |
| CITADEL ADVISORS LLC | $17.877 | 10.100 | 0,10% | Verkaufsoption |
| Persistent Asset Partners Ltd | $10.409 | 5.881 | 0,06% | Aktien |
| Cubist Systematic Strategies, LLC | $8.972 | 4.673 | 0,05% | Aktien |
| MORGAN STANLEY | $885 | 500 | 0,00% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $708 | 400 | 0,00% | Aktien |
| HRT FINANCIAL LP | $128 | 72.486 | 0,00% | Aktien |
| GROUP ONE TRADING LLC | $90 | 51 | 0,00% | Aktien |
| Virtu Financial LLC | $65 | 36.921 | 0,00% | Aktien |
| SG Americas Securities, LLC | $25 | 13.913 | 0,00% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF PARTNERS L P/IL, BVF INC/IL, LAMPERT MARK N | 4. August 2026 | 9,99% | Erste Einreichung | Vorstandskampagne | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 17 Insider · 4 Führungskräfte · 5 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Spiros Jamas | Chief Executive Officer | 18. Januar 2022 P | 10.000 | 0 | 0 | $0 |
| Ramesh Ratan | U.S.based CFO | 19. Januar 2022 P | 10.000 | 0 | 0 | $0 |
| Phillip Schwartz | President of R&D | 20. Januar 2022 P | 607.410 | 0 | 0 | $0 |
| Arthur C Santora II | Chief Medical Officer | 24. April 2023 A | · | 0 | 0 | $0 |
| Gerald M Ostrov | Direktor | 1. Januar 2026 A | 75.657 | 0 | 0 | $0 |
| Gerald M Lieberman | Direktor | 1. Januar 2026 A | 338.454 | 0 | 0 | $0 |
| Ron Mayron | Direktor | 1. Januar 2024 A | 7.000 | 0 | 0 | $0 |
| Roger Garceau | Direktor | 1. Januar 2024 A | · | 0 | 0 | $0 |
| Gregory Burshtein | · | 7. August 2026 A | 189.033 | 0 | 0 | $0 |
| Haya Taitel | · | 7. August 2026 A | 119.269 | 1 | 0 | $11.100 |
| Dana Yaacov-Garbeli | · | 7. August 2026 A | 171.441 | 0 | 0 | $0 |
| Yonatan Malca | · | 7. August 2026 A | 100.231 | 0 | 0 | $0 |
| Sean Ellis | · | 7. August 2026 A | 208.132 | 2 | 0 | $34.620 |
| Hillel Galitzer | · | 7. August 2026 A | 163.566 | 0 | 0 | $0 |
| Miranda Jayne Toledano | · | 7. August 2026 A | 847.135 | 1 | 0 | $19.910 |
| Geno J Germano | · | 7. August 2026 A | 65.014 | 2 | 0 | $55.800 |
| Steven D Rubin | · | 7. August 2026 A | 34.117 | 2 | 0 | $19.450 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ENTX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 7 Analysten
KAUF
Median-Ziel
$9.50
+232,2%
2 28,6%
Starker Kauf
4 57,1%
Kauf
1 14,3%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
4 Analysten · 2026-10-02Mittelwert-Ziel $9.75 +240,9%
← Unter allen Zielen
Aktueller Preis $2.86
Tief$9.00
Mittelwert$9.75
Hoch$11.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 7, 2026